J&J, Pfizer, Russian COVID-19 Vaccines Set For Indian Approval In '21
Multiple Supply, R&D, Funding Deals But Hesitancy An Issue?
Multiple COVID-19 vaccines, including from J&J, Pfizer and RDIF, are seen gaining approvals in India in 2021, following on from a raft of R&D, manufacturing and marketing tie-ups, as well as other developments, in the action-packed field last year.
